Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableApproved For MarketingNCT05164250
What this trial is testing

Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Regeneron Pharmaceuticals
Large-scale testing (Phase 3)UnknownNCT04287660
What this trial is testing

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT04065789
What this trial is testing

Carfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Patients

Who this might be right for
Myeloma MultipleMyeloma, Plasma-CellMyeloma-Multiple+1 more
Tel-Aviv Sourasky Medical Center 41
Not applicableStudy completedNCT05742217
What this trial is testing

Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Pfizer 121
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07842198
What this trial is testing

Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy

Who this might be right for
Large B-Cell Lymphoma (LBCL)Multiple Myeloma (MM)Gut Microbiota
Zealand University Hospital 150
Not applicableActive Not RecruitingNCT00048958
What this trial is testing

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+1 more
Alliance for Clinical Trials in Oncology 9,000
Not applicableLooking for participantsNCT07248176
What this trial is testing

Universal CAR-T Cell Therapy for MM

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma, Refractory
Bioray Laboratories 6
Very early researchLooking for participantsNCT07771803
What this trial is testing

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

Who this might be right for
AML (Acute Myeloid Leukemia)Multiple Myeloma Refractory
Roger Strair 20
Not applicableNot Yet RecruitingNCT07746232
What this trial is testing

Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"

Who this might be right for
Multiple Myeloma (MM)
Fondazione EMN Italy Onlus 92
Large-scale testing (Phase 3)Study completedNCT01413178
What this trial is testing

Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 205
Very early researchLooking for participantsNCT07101705
What this trial is testing

An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies

Who this might be right for
Multiple Myeloma (MM)Non-Hodgkin Lymphoma (NHL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Testing effectiveness (Phase 2)Study completedNCT01651039
What this trial is testing

Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Ajai Chari 32
Early research (Phase 1)Study completedNCT00258245
What this trial is testing

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT00395967
What this trial is testing

AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone

Who this might be right for
Multiple MyelomaLymphoma, Non-Hodgkin's
Genzyme, a Sanofi Company 5
Early research (Phase 1)Study completedNCT00854139
What this trial is testing

Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)

Who this might be right for
Multiple MyelomaEnd Stage Renal Disease
Massachusetts General Hospital 10
Early research (Phase 1)Study completedNCT02211014
What this trial is testing

An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Acerta Pharma BV 27
Not applicableUnknownNCT04143932
What this trial is testing

Multiple Myeloma Turkish Prospective Patient Registry

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Turkish Hematology Association 1,000
Not applicableLooking for participantsNCT07100067
What this trial is testing

LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma(MM)
Nanjing Legend Biotech Co. 35
Large-scale testing (Phase 3)Active Not RecruitingNCT03844048
What this trial is testing

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Who this might be right for
Chronic Lymphocytic LeukemiaAcute Myeloid LeukemiaMultiple Myeloma+3 more
AbbVie 165
Testing effectiveness (Phase 2)Ended earlyNCT00499239
What this trial is testing

A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)

Who this might be right for
Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaMultiple Myeloma
Gilead Sciences 32
Next Page